Drug Discovery

As the life science industry faces increasing competition—as well as global regulatory and pricing pressures—outsourcing portions or all of manufacturing is becoming increasingly prevalent....

In this sponsored GENcast listen to a conversation with Dr. Klaus Lun, Executive Vice President of Life Science Business for Tecan, provide his perspective on global developments pertaining to COVID-19 and other timely topics.

In a previous podcast, we heard about the power of virtual collaborations during a pharmaceutical company’s push to meet their manufacturing goals during a...

Currently, almost 60 percent of drugs in development are being created by emerging biotech companies focused on therapies for niche diseases with small patient...

The biomanufacturing industry is currently undergoing a revolution in how it produces biopharmaceutical products. The driving force behind this paradigm shift is known as...

In this GENcast, our guest will tell us more about HTS using 3D cell models and why they are so crucial for current drug discovery projects. Moreover, he will provide scientific insight into the 3D cell panel screening service—called OncoSignature™—which uses a library of 200 cell lines grown in 3D spheroids to provide a better understanding of candidate cancer therapeutics.

With regions of the world cycling through societal re-openings and shutdowns due to the ongoing coronavirus pandemic, pharma and life science companies are tasked...

In this GENcast, our guest will tell us more about HTS using 3D cell models and why they are so crucial for current drug discovery projects. Moreover, he will provide scientific insight into the 3D cell panel screening service—called OncoSignature™—which uses a library of 200 cell lines grown in 3D spheroids to provide a better understanding of candidate cancer therapeutics.

Sponsor: Domain TherapeuticsIn this GEN webinar, sponsored by Domain Therapeutics, we will discuss how the use of enhanced bystander bioluminescence energy transfer (ebBRET) biosensors and tag-free G protein coupled receptors (GPCRs) can help empower the discovery of next-gen therapeutics.

Sponsor: Sartorius Stedim BiotechIn this GEN webinar, sponsored by Sartorius Stedim Biotech, we will hear how application of modern bottle and flask closure technologies in combination with machine automation can compress a cell expansion process map to bring about a low-risk, streamlined workflow with reduced operating costs.